vTv Therapeutics Inc
NASDAQ:VTVT

Watchlist Manager
vTv Therapeutics Inc Logo
vTv Therapeutics Inc
NASDAQ:VTVT
Watchlist
Price: 14.9 USD 7.12%
Market Cap: 44.8m USD
Have any thoughts about
vTv Therapeutics Inc?
Write Note

vTv Therapeutics Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

vTv Therapeutics Inc
Total Current Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
vTv Therapeutics Inc
NASDAQ:VTVT
Total Current Assets
$46.2m
CAGR 3-Years
60%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Current Assets
$27.8B
CAGR 3-Years
-1%
CAGR 5-Years
7%
CAGR 10-Years
5%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Assets
$13.1B
CAGR 3-Years
-2%
CAGR 5-Years
-14%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Total Current Assets
$26.8B
CAGR 3-Years
3%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Assets
$9.8B
CAGR 3-Years
3%
CAGR 5-Years
15%
CAGR 10-Years
20%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Assets
$19.3B
CAGR 3-Years
12%
CAGR 5-Years
22%
CAGR 10-Years
24%

See Also

What is vTv Therapeutics Inc's Total Current Assets?
Total Current Assets
46.2m USD

Based on the financial report for Jun 30, 2024, vTv Therapeutics Inc's Total Current Assets amounts to 46.2m USD.

What is vTv Therapeutics Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
65%

Over the last year, the Total Current Assets growth was 232%. The average annual Total Current Assets growth rates for vTv Therapeutics Inc have been 60% over the past three years , 65% over the past five years .

Back to Top